AML patient samples
| Patient | FAB | Description | Specimen Type | % blasts | Collection date |
| 1 | M3 | 15-yr-old APML with t(15;17) | BMA | 73% | 11-24-05 |
| 2 | M5A | 6-yr-old relapsed monoblastic AML without differentiation | BMA | 76% | 5-10-05 |
| 3 | M4 | 14-yr-old myelomonocytic AML with t(9;11) | CD34+ BMA | 97% | 12-7-07 |
| 4 | M1 | 12-yr-old relapsed undifferentiated AML | leukapheresis | 94% | 7-15-04 |
| 5 | M4 | 16-yr-old myelomonocytic AML | BMA | 68% | 8-2-05 |
| Patient | FAB | Description | Specimen Type | % blasts | Collection date |
| 1 | M3 | 15-yr-old APML with t(15;17) | BMA | 73% | 11-24-05 |
| 2 | M5A | 6-yr-old relapsed monoblastic AML without differentiation | BMA | 76% | 5-10-05 |
| 3 | M4 | 14-yr-old myelomonocytic AML with t(9;11) | CD34+ BMA | 97% | 12-7-07 |
| 4 | M1 | 12-yr-old relapsed undifferentiated AML | leukapheresis | 94% | 7-15-04 |
| 5 | M4 | 16-yr-old myelomonocytic AML | BMA | 68% | 8-2-05 |
AML, acute myelogenous leukemia; APML, acute promyelocytic leukemia; BMA, bone marrow aspirate.